Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1233003.RAfUK42_2Ze6TKSxnuuY3fZitpCFx3qxSnuE_7PIZBSmw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1233003.RAfUK42_2Ze6TKSxnuuY3fZitpCFx3qxSnuE_7PIZBSmw130_assertion type Assertion NP1233003.RAfUK42_2Ze6TKSxnuuY3fZitpCFx3qxSnuE_7PIZBSmw130_head.
- NP1233003.RAfUK42_2Ze6TKSxnuuY3fZitpCFx3qxSnuE_7PIZBSmw130_assertion description "[This is the first report of recurrent translocations involving TYK2, and it highlights the novel therapeutic opportunities in the treatment of CD30-positive LPDs with TYK2 translocations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233003.RAfUK42_2Ze6TKSxnuuY3fZitpCFx3qxSnuE_7PIZBSmw130_provenance.
- NP1233003.RAfUK42_2Ze6TKSxnuuY3fZitpCFx3qxSnuE_7PIZBSmw130_assertion evidence source_evidence_literature NP1233003.RAfUK42_2Ze6TKSxnuuY3fZitpCFx3qxSnuE_7PIZBSmw130_provenance.
- NP1233003.RAfUK42_2Ze6TKSxnuuY3fZitpCFx3qxSnuE_7PIZBSmw130_assertion SIO_000772 25349176 NP1233003.RAfUK42_2Ze6TKSxnuuY3fZitpCFx3qxSnuE_7PIZBSmw130_provenance.
- NP1233003.RAfUK42_2Ze6TKSxnuuY3fZitpCFx3qxSnuE_7PIZBSmw130_assertion wasDerivedFrom befree-2016 NP1233003.RAfUK42_2Ze6TKSxnuuY3fZitpCFx3qxSnuE_7PIZBSmw130_provenance.
- NP1233003.RAfUK42_2Ze6TKSxnuuY3fZitpCFx3qxSnuE_7PIZBSmw130_assertion wasGeneratedBy ECO_0000203 NP1233003.RAfUK42_2Ze6TKSxnuuY3fZitpCFx3qxSnuE_7PIZBSmw130_provenance.